These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27145974)

  • 1. Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy.
    Dobson NR; Liu X; Rhein LM; Darnall RA; Corwin MJ; McEntire BL; Ward RM; James LP; Sherwin CM; Heeren TC; Hunt CE
    Br J Clin Pharmacol; 2016 Sep; 82(3):754-61. PubMed ID: 27145974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity.
    García-Robles A; Solaz-García Á; Verdú-Andrés J; Andrés JLP; Cañada-Martínez AJ; Pericás CC; Ponce-Rodriguez HD; Vento M; González PS
    Eur J Pediatr; 2022 Dec; 181(12):4175-4182. PubMed ID: 36169712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants.
    Khanna NN; Bada HS; Somani SM
    J Pediatr; 1980 Mar; 96(3 Pt 1):494-9. PubMed ID: 7359248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity.
    Lee TC; Charles BG; Steer PA; Flenady VJ
    Ther Drug Monit; 1996 Jun; 18(3):288-93. PubMed ID: 8738770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of saliva in therapeutic drug monitoring of caffeine in preterm infants.
    de Wildt SN; Kerkvliet KT; Wezenberg MG; Ottink S; Hop WC; Vulto AG; van Den Anker JN
    Ther Drug Monit; 2001 Jun; 23(3):250-4. PubMed ID: 11360033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Variability of Caffeine in Routinely Treated Preterm Infants: Preliminary Considerations on Developmental Changes of Systemic Clearance.
    Taguchi M; Kawasaki Y; Katsuma A; Mito A; Tamura K; Makimoto M; Yoshida T
    Biol Pharm Bull; 2021 Jan; 44(1):69-74. PubMed ID: 33116005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.
    Patel P; Mulla H; Kairamkonda V; Spooner N; Gade S; Della Pasqua O; Field DJ; Pandya HC
    Br J Clin Pharmacol; 2013 Mar; 75(3):805-13. PubMed ID: 22822712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of salivary and plasma cortisol levels in preterm infants: results of a prospective observational study and systematic review of the literature.
    Maas C; Ringwald C; Weber K; Engel C; Poets CF; Binder G; Bassler D
    Neonatology; 2014; 105(4):312-8. PubMed ID: 24603497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of salivary and cord blood cortisol in preterm infants.
    Chou IC; Lien HC; Lin HC; Fu JJ; Kao CH; Tsai CH; Lin PH; Tsai FJ
    J Pediatr Endocrinol Metab; 2011; 24(1-2):85-8. PubMed ID: 21528822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants.
    Cohen-Wolkowiez M; Ouellet D; Smith PB; James LP; Ross A; Sullivan JE; Walsh MC; Zadell A; Newman N; White NR; Kashuba AD; Benjamin DK
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1828-37. PubMed ID: 22252819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age.
    Engbers AGJ; Völler S; Poets CF; Knibbe CAJ; Reiss IKM; Koch BCP; Flint RB; Simons SHP
    Neonatology; 2021; 118(1):106-113. PubMed ID: 33626528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of caffeine in preterm infants: Could saliva be an alternative to serum?
    Chaabane A; Chioukh FZ; Chadli Z; Ben Fredj N; Ben Ameur K; Ben Hmida H; Boughattas NA; Monastiri K; Aouam K
    Therapie; 2017 Dec; 72(6):685-689. PubMed ID: 28964570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid concentrations of caffeine following oral drug administration: correlation with salivary and plasma concentrations.
    Soto J; Sacristan JA; Alsar MJ
    Ther Drug Monit; 1994 Feb; 16(1):108-10. PubMed ID: 8160248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of caffeine in saliva by high-performance liquid chromatography: new sampling method for saliva using filter paper.
    Suzuki Y; Uematsu T; Mizuno A; Fujii K; Nakashima M
    Ther Drug Monit; 1989; 11(1):88-92. PubMed ID: 2911858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post-marketing study to support paediatric labelling in China.
    Gao XB; Zheng Y; Yang F; Wang CH; Jiang ZH; Wu YE; Jacqz-Aigrain E; Ni SQ; Zhao W
    Br J Clin Pharmacol; 2021 Mar; 87(3):1155-1164. PubMed ID: 32687613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva for Assessing Vitamin A Status in Extremely Preterm Infants: A Diagnostic Study.
    Rakshasbhuvankar AA; Clarke MW; Simmer K; Patole SK; Pillow JJ
    Neonatology; 2020; 117(3):365-368. PubMed ID: 32114572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC; Charles B; Steer P; Flenady V; Shearman A
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period.
    Ide H; Kawasaki Y; Tamura K; Yoshida T; Fujihara R; Hara A; Taguchi M
    Biol Pharm Bull; 2024; 47(4):861-867. PubMed ID: 38644196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of piperacillin using scavenged samples from preterm infants.
    Cohen-Wolkowiez M; Benjamin DK; Ross A; James LP; Sullivan JE; Walsh MC; Zadell A; Newman N; White NR; Kashuba AD; Ouellet D
    Ther Drug Monit; 2012 Jun; 34(3):312-9. PubMed ID: 22569355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva versus Plasma Therapeutic Drug Monitoring of Gentamicin in Jordanian Preterm Infants. Development of a Physiologically-Based Pharmacokinetic (PBPK) Model and Validation of Class II Drugs of Salivary Excretion Classification System.
    Idkaidek N; Hamadi S; Bani-Domi R; Al-Adham I; Alsmadi M; Awaysheh F; Aqrabawi H; Al-Ghazawi A; Rabayah A
    Drug Res (Stuttg); 2020 Oct; 70(10):455-462. PubMed ID: 32877949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.